Arizona State Retirement System Raises Position in Henry Schein, Inc. (NASDAQ:HSIC)

Arizona State Retirement System raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 0.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,890 shares of the company’s stock after purchasing an additional 149 shares during the quarter. Arizona State Retirement System’s holdings in Henry Schein were worth $2,717,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Baystate Wealth Management LLC increased its position in shares of Henry Schein by 2,500.0% during the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock valued at $39,000 after acquiring an additional 500 shares during the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Henry Schein during the fourth quarter valued at approximately $39,000. Neo Ivy Capital Management purchased a new stake in shares of Henry Schein during the third quarter valued at approximately $46,000. Covestor Ltd increased its position in shares of Henry Schein by 88.4% during the first quarter. Covestor Ltd now owns 861 shares of the company’s stock valued at $75,000 after acquiring an additional 404 shares during the last quarter. Finally, RVW Wealth LLC bought a new position in Henry Schein during the third quarter valued at $104,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Down 1.8 %

HSIC opened at $71.86 on Thursday. The company has a market cap of $9.23 billion, a P/E ratio of 22.81, a P/E/G ratio of 1.80 and a beta of 0.87. The business’s 50-day moving average price is $74.99 and its 200-day moving average price is $72.60. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $85.75.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). The company had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The firm’s quarterly revenue was down 10.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.21 EPS. On average, equities analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. increased their price objective on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. SVB Leerink started coverage on Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. Piper Sandler raised their price target on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $81.09.

Insider Transactions at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.